drugset / Trial / NCT00337623

Impact of Systemic Corticosteroid Therapy on Lens Transparency and Quantification of Lens Autofluorescence.

NCT00337623

Non-randomizedSingle-groupOpen-labelPrevention

Summary

Corticosteroid therapy is usually regarded as a risk factor for the development of posterior subcapsular cataracts but prospective studies on this topic and accurate assessment of this potential adverse effect are lacking. We will evaluate changes of lens transparency after administration of systemic corticosteroid therapy for at least one year with Scheimpflug photography and quantification of lens autofluorescence.

Timeline

Start
2000-06
Primary completion
Completion
2006-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Prednisolone Other / unclassified